LIPOINT
DEAD

Serial Number

77343408

Owner

LiPoint Inc.

Filing Date

Dec 4, 2007

Add to watchlist:

No watchlists yet
View on USPTO

LIPOINT Trademark

Serial Number: 77343408

LIPOINT is a trademark filed by LiPoint Inc. on December 4, 2007. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

LiPoint Inc.

6393 N Desert Wind Circle
Tucson, AZ 85750

Entity Type: 03

Trademark Details

Filing Date

December 4, 2007

Registration Date

Not Registered

Published for Opposition

September 8, 2009

Goods & Services

Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Almond oil for pharmaceutical purposes; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes,and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations namely,antidepressants; Pharmaceutical preparations namely,appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Almond oils for pharmaceutical purposes; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Astringents; Cardiovascular pharmaceuticals

Injection device for pharmaceuticals; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical apparatus for introducing pharmaceutical preparations into the human body

Pharmaceutical drug development services; Research and development of vaccines and medicines; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research on the subject of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 5, 2011 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 5, 2011 ABN6
WITHDRAWAL OF ATTORNEY GRANTED
Jan 31, 2011 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jan 31, 2011 WOAR
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Dec 21, 2010 EXRA
SOU EXTENSION 2 GRANTED
Dec 20, 2010 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 20, 2010 AITU
SOU EXTENSION 2 FILED
Dec 1, 2010 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 1, 2010 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jun 3, 2010 EXRA
SOU EXTENSION 1 GRANTED
Jun 1, 2010 EX1G
SOU EXTENSION 1 FILED
Jun 1, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 1, 2010 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 1, 2009 NOAM
PUBLISHED FOR OPPOSITION
Sep 8, 2009 PUBO
NOTICE OF PUBLICATION
Aug 19, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 6, 2009 PREV
ASSIGNED TO LIE
Aug 5, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 23, 2009 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2009 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2009 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2009 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2009 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2009 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2009 TCCA
PETITION TO REVIVE-GRANTED
Jan 5, 2009 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 5, 2009 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 6, 2008 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 6, 2008 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 14, 2008 GNRN
NON-FINAL ACTION E-MAILED
Mar 14, 2008 GNRT
NON-FINAL ACTION WRITTEN
Mar 14, 2008 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2008 DOCK
NEW APPLICATION ENTERED
Dec 7, 2007 NWAP